Levetiracetam May be the First Choice for Managing Epilepsia Partialis Continua Related to Ischemic Stroke
Author(s) -
Mehmet İlker Yön,
Ersin Kasım Ulusoy,
Şule Bilen,
Merve Ecem Erdoğan Yön
Publication year - 2016
Publication title -
deleted journal
Language(s) - English
Resource type - Journals
ISSN - 2149-2247
DOI - 10.5152/etd.2016.150054
Subject(s) - levetiracetam , medicine , epilepsia partialis continua , stroke (engine) , ischemic stroke , anesthesia , neuroscience , epilepsy , psychiatry , status epilepticus , ischemia , mechanical engineering , engineering , biology
An 82-year-old, right-handed male patient was admitted to the emergency room because of continuous rhythmic clonic movements of the right forearm and hand. He was diagnosed with epilepsia partialis continua (EPC) and treated successfully with levetiracetam. In conclusion, we recommend levetiracetam as the first line treatment for EPC, which is mostly refractory to classical antiepileptic drugs.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom